Read the whole PR! But reason for fall
$Verve Therapeutics(VERV.US$ However, the sixth participant treated in the 0.45 mg/kg cohort experienced a Grade 3 drug-induced transient increase in serum alanine aminotransferase (ALT) as well as a serious adverse event of Grade 3 drug-induced thrombocytopenia within the first four days after dosing. The participant did not experience any bleeding or other symptoms related to the laboratory abnormalities, and the abnormalities resolved fully within a few days.
In light of such observed laboratory abnormalities associated with VERVE-101, Verve, in consultation with the study's independent data and safety monitoring board (DSMB), has decided to pause enrollment in the Heart-1 clinical trial. Verve is conducting an investigation into the laboratory abnormalities and based on those results, expects to work with regulatory authorities to define a path forward for VERVE-101. These safety events were reported to the U.S. Food and Drug Administration (FDA), MHRA, and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). The VERVE-101 Investigational New Drug Application (IND) and other CTAs remain active.
In light of such observed laboratory abnormalities associated with VERVE-101, Verve, in consultation with the study's independent data and safety monitoring board (DSMB), has decided to pause enrollment in the Heart-1 clinical trial. Verve is conducting an investigation into the laboratory abnormalities and based on those results, expects to work with regulatory authorities to define a path forward for VERVE-101. These safety events were reported to the U.S. Food and Drug Administration (FDA), MHRA, and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). The VERVE-101 Investigational New Drug Application (IND) and other CTAs remain active.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
HUAT AH UP AH : From the standpoint of the company, they need to clear this out before can proceed further. This is the truth.
TrytosaveabitOP HUAT AH UP AH: Agreed!
HUAT AH UP AH : Just whether market overreacted to this. Only time can tell.
TrytosaveabitOP HUAT AH UP AH: True
买跌不追涨 : Have you bought it? I entered before the market
TrytosaveabitOP 买跌不追涨: Nooo!
买跌不追涨 TrytosaveabitOP: No fear, within the day, the cost is low enough
TrytosaveabitOP 买跌不追涨: If market decides it’s a bit of a overreaction? Yes! If market looks at it the same as I do? Well the bottom is still a ways off? GL
买跌不追涨 TrytosaveabitOP: 20 points is enough
TrytosaveabitOP 买跌不追涨: Absolutely! If I woulda caught when it was a bit above 7? I would’ve scalped it! But I’ve got to many trades going and missed that lower price! Make that bank but secure profits my friend
View more comments...